Ann Marie O'Neill/Linkedin
Aug 22, 2025, 14:36
Join the Thrombosis UK Survey on Severe Thrombophilia: Improve Diagnosis and Treatment Worldwide
Ann Marie O’Neill, a member of The World Thrombosis Day Steering Committee, shared a post on Linkedin:
“Help shape the future of thrombophilia care
Patients living with severe thrombophilia are invited to participate in an important research opportunity.
This research initiative aims to gather critical insights directly from patients to inform global efforts in improving diagnosis, treatment protocols and overall patient outcomes.
The survey is for patients living with severe thrombophilia, including:
- Antithrombin Deficiency
- Protein C Deficiency
- Protein S Deficiency
- Homozygous Factor V Leiden
- Combinations such as Factor V Leiden and Prothrombin 20210.”
Patients living with severe thrombophilia are invited to participate in an important research opportunity developed by Thrombosis UK.
For the survey, check here.
Find similar posts on Hemostasis Today.
-
Jan 12, 2026, 14:46A Behcet Disease with Aortic Thrombosis: Alexandru Stieber Shares A Peculiar Case
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies